A 66-year-old @entity1 showed central nervous system (CNS) and epididymis involvement after concurrent chemoradiotherapy for extranodal natural killer/ @entity784 , nasal type (ENKL). The @entity1 experienced continuous nasal obstruction. CT revealed a mass in the nasal cavity and paranasal sinuses. Biopsy of the nasal cavity mass showed it to be ENKL. Based on bone marrow biopsy and 18F-FDG PET/CT findings, the clinical stage was suspected to be IIE. The sites involved were the nasal cavity, paranasal sinuses, and cervical lymph nodes. We performed concurrent chemoradiotherapy consisting of a 67% dose of @entity1652 and involved field radiation therapy towards his head and neck. Head and neck CT confirmed a therapeutic response. After receiving concurrent chemoradiotherapy, the @entity1 complained of perineal discomfort. Ultrasonography revealed swelling of the @entity1002 . Left epididymis biopsy showed ENKL involvement and lumbar puncture revealed CNS involvement. The findings of this case suggest that evaluation of CNS involvement might be an essential part of the initial workup for some ENKL @entity1 .

Extranodal natural killer/ XXXX , nasal type developing central nervous system and epididymis involvement immediately after concurrent chemoradiotherapy.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'man'] @entity784 :: ('MESH:D016399', 'Disease') :: ['T-cell lymphoma'] @entity1652 :: ('MESH:D009471', 'Disease') :: ['DeVIC'] @entity1002 :: ('MESH:D018487', 'Disease') :: ['left epididymis']
@entity784 :: (MESH:D016399,Disease) :: ['T-cell lymphoma']
